Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2.
Nuclear factor E2-related factor 2 (Nrf2) appears to be an attractive therapeutic target for the treatment of cardiac disease. We investigated whether a synthetic triterpenoid derivative of dihydro-CDDO-trifluoroethylamide (dh404), a novel Nrf2 activator, protects against pathological cardiac respon...
Main Authors: | Yifan Xing, Ting Niu, Wenjuan Wang, Jinqing Li, Siying Li, Joseph S Janicki, Stacey Ruiz, Colin J Meyer, Xing Li Wang, Dongqi Tang, Yuxia Zhao, Taixing Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3444497?pdf=render |
Similar Items
-
Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.
by: Lichuan Yang, et al.
Published: (2009-06-01) -
The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity
by: Laura Casares, et al.
Published: (2022-05-01) -
The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage
by: Kristiana M. Amirova, et al.
Published: (2023-05-01) -
CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer
by: Dorrah Deeb, et al.
Published: (2010-10-01) -
The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
by: Ajit A Kulkarni, et al.
Published: (2013-01-01)